Company: VCYT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001384101-25-000014
Chunk: 166

Company: VERACYTE, INC.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 166
---
 - cost of revenue11,552 18,464 19,273 Total cost of revenue147,619 131,367 120,855 Gross profit298,145 229,684 175,681 Operating expenses:Research and development69,294 57,305 40,603 Selling and marketing95,434 101,490 97,560 General and administrative110,610 86,229 73,200 Impairment of long-lived assets3,368 68,349 3,318 Intangible asset amortization - operating expenses3,297 2,106 2,081 Total operating expenses282,003 315,479 216,762 Income (loss) from operations16,142 (85,795)(41,081)Other income, net9,602 9,183 4,654 Income (loss) before income taxes25,744 (76,612)(36,427)Income tax provision (benefit)1,606 (2,208)133 Net income (loss)$24,138 $(74,404)$(36,560)Earnings (loss) per share:Basic$0.32 $(1.02)$(0.51)Diluted$0.31 $(1.02)$(0.51)Shares used to compute earnings (loss) per common share:Basic76,484,759 72,644,487 71,549,204 Diluted78,163,217 72,644,487 71,549,204 

The accompanying notes are an integral part of these consolidated financial statements.

85

VERACYTE, INC.

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

 Year Ended December 31, 202420232022Net income (loss)$24,138 $(74,404)$(36,560)Other comprehensive income (loss):Change in currency translation adjustments(12,072)7,328 (16,263)Net comprehensive income (loss)$12,066 $(67,076)$(52,823)

The accompanying notes are an integral part of these consolidated financial statements.

86

VERACYTE, INC.

Consolidated Statements of Stockholders' Equity

(in thousands)

 AdditionalPaid-inCapitalAccumulatedDeficitAccumulated Other Comprehensive LossTotalStockholders'Equity Common Stock SharesAmountBalance